These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4552465)

  • 21. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
    Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
    J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay.
    Lopez C; O'Reilly RJ
    J Immunol; 1977 Mar; 118(3):895-902. PubMed ID: 191528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage migration inhibition as a correlate of cell-mediated immunity to herpes simplex virus type 2 in mice.
    Mogensen SC
    Immunobiology; 1982; 162(1):28-38. PubMed ID: 6286467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction: interaction of humoral and cellular mechanisms in tumor immunity.
    Hellström KE
    Natl Cancer Inst Monogr; 1972 Dec; 35():221-2. PubMed ID: 4667436
    [No Abstract]   [Full Text] [Related]  

  • 26. Familial herpes simplex infection associated with activation of the complement system.
    Kapadia A; Gupta S; Good RA; Day NK
    Am J Med; 1979 Jul; 67(1):122-6. PubMed ID: 380333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-mediated immunity to herpes simplex virus in man.
    Russell AS
    J Infect Dis; 1974 Feb; 129(2):142-6. PubMed ID: 4359402
    [No Abstract]   [Full Text] [Related]  

  • 28. Cellular immunity and herpesvirus infections in cardiac-transplant patients.
    Rand KH; Rasmussen LE; Pollard RB; Arvin A; Merigan TC
    N Engl J Med; 1977 Jun; 296(24):1372-7. PubMed ID: 193008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological reactions against Mycoplasma pneumoniae in multiple sclerosis: preliminary findings.
    Maida E
    J Neurol; 1983; 229(2):103-11. PubMed ID: 6190995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune responsiveness of patients with autoimmune diseases and immunodeficiency.
    Gergely P; Láng I; Nékám K; Kalmár L; Török K; Lévai J; Gonzales-Cabello R; Petrányi G
    Ann Immunol Hung; 1979; 19():105-15. PubMed ID: 162194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of recurrent infection by Herpesvirus hominis.
    Bierman SM
    Arch Dermatol; 1976 Oct; 112(10):1459-61. PubMed ID: 183607
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
    Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
    J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ulcerative colitis.
    Jewell DP
    Front Gastrointest Res; 1975; 1():125-41. PubMed ID: 1098988
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymus transplantation. Reconstitution of cellular immunity in a four-year-old patient with T-cell deficiency.
    Businco L; Rezza E; Giunchi G; Aiuti F
    Clin Exp Immunol; 1975 Jul; 21(1):32-38. PubMed ID: 171111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro models of cellular hypersensitivity.
    Churchill WH
    Adv Biol Skin; 1971; 11():345-55. PubMed ID: 4950203
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro-demonstration of cellular hypersensitivity to tumour antigens in man.
    Andersen V; Kjaer M; Bendixen G
    Ser Haematol; 1972; 5(5):3-21. PubMed ID: 4598039
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental ulcerative herpetic keratitis. I. Systemic immune responses and resistance to corneal infection.
    Carter C; Easty DL
    Br J Ophthalmol; 1981 Feb; 65(2):77-81. PubMed ID: 6257272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell mediated lympholysis in man after sensitization of effector lymphocytes through mixed leukocyte cultures.
    Lightbody J; Bernoco D; Miggiano VC; Ceppellini R
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):243-54. PubMed ID: 5155939
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements.
    Perlmann P; Holm G; Stejskal V
    Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.